Anxiety Disorder
Bild generiert von KI
UCSF researchers test LSD-based MM120 for generalized anxiety disorder
Von KI berichtet Bild generiert von KI Fakten geprüft
UCSF neuroscientist Jennifer Mitchell and collaborators are evaluating MM120, a pharmaceutical form of LSD, as a potential treatment for generalized anxiety disorder. A randomized clinical trial published in JAMA found that a single dose reduced anxiety symptoms versus placebo, with benefits persisting up to 12 weeks in the optimal dose group, according to the study and the drug’s sponsor.